Adiponectin GWAS loci harboring extensive allelic heterogeneity exhibit distinct molecular consequences.
Adiponectin
/ genetics
Adipose Tissue
/ metabolism
Alleles
Cadherins
/ genetics
DNA-Binding Proteins
/ genetics
Gene Frequency
/ genetics
Genetic Predisposition to Disease
Genome-Wide Association Study
/ methods
Humans
Insulin Receptor Substrate Proteins
/ genetics
Male
Metabolic Syndrome
/ genetics
Phenotype
Polymorphism, Single Nucleotide
/ genetics
Quantitative Trait Loci
/ genetics
Regulatory Sequences, Nucleic Acid
Transcription Factors
/ genetics
Journal
PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
15
05
2020
accepted:
29
07
2020
revised:
23
09
2020
pubmed:
12
9
2020
medline:
18
11
2020
entrez:
11
9
2020
Statut:
epublish
Résumé
Loci identified in genome-wide association studies (GWAS) can include multiple distinct association signals. We sought to identify the molecular basis of multiple association signals for adiponectin, a hormone involved in glucose regulation secreted almost exclusively from adipose tissue, identified in the Metabolic Syndrome in Men (METSIM) study. With GWAS data for 9,262 men, four loci were significantly associated with adiponectin: ADIPOQ, CDH13, IRS1, and PBRM1. We performed stepwise conditional analyses to identify distinct association signals, a subset of which are also nearly independent (lead variant pairwise r2<0.01). Two loci exhibited allelic heterogeneity, ADIPOQ and CDH13. Of seven association signals at the ADIPOQ locus, two signals colocalized with adipose tissue expression quantitative trait loci (eQTLs) for three transcripts: trait-increasing alleles at one signal were associated with increased ADIPOQ and LINC02043, while trait-increasing alleles at the other signal were associated with decreased ADIPOQ-AS1. In reporter assays, adiponectin-increasing alleles at two signals showed corresponding directions of effect on transcriptional activity. Putative mechanisms for the seven ADIPOQ signals include a missense variant (ADIPOQ G90S), a splice variant, a promoter variant, and four enhancer variants. Of two association signals at the CDH13 locus, the first signal consisted of promoter variants, including the lead adipose tissue eQTL variant for CDH13, while a second signal included a distal intron 1 enhancer variant that showed ~2-fold allelic differences in transcriptional reporter activity. Fine-mapping and experimental validation demonstrated that multiple, distinct association signals at these loci can influence multiple transcripts through multiple molecular mechanisms.
Identifiants
pubmed: 32915782
doi: 10.1371/journal.pgen.1009019
pii: PGENETICS-D-20-00778
pmc: PMC7511027
doi:
Substances chimiques
ADIPOQ protein, human
0
Adiponectin
0
Cadherins
0
DNA-Binding Proteins
0
H-cadherin
0
IRS1 protein, human
0
Insulin Receptor Substrate Proteins
0
PBRM1 protein, human
0
Transcription Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009019Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM067553
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK072193
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL028481
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062370
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK062370
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA HG000024
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL069768
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK105561
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK093757
Pays : United States
Organisme : NHLBI NIH HHS
ID : F31 HL146121
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL129982
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007092
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Hum Genet. 2018 Nov 1;103(5):637-653
pubmed: 30388398
Am J Hum Genet. 2017 Jul 6;101(1):5-22
pubmed: 28686856
Mol Cell Endocrinol. 2016 Jun 15;428:49-57
pubmed: 26996131
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
PLoS Genet. 2014 Sep 11;10(9):e1004633
pubmed: 25211022
PLoS Genet. 2012;8(3):e1002607
pubmed: 22479202
Diabetes. 2007 May;56(5):1198-209
pubmed: 17303804
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
Cell. 2016 Oct 6;167(2):355-368.e10
pubmed: 27693352
Cell. 2019 Oct 17;179(3):589-603
pubmed: 31607513
Br J Pharmacol. 2017 Nov;174(22):4007-4020
pubmed: 27629236
Nature. 2020 Jun;582(7811):240-245
pubmed: 32499647
Am J Hum Genet. 2017 May 4;100(5):789-802
pubmed: 28475861
Nature. 2015 Oct 1;526(7571):82-90
pubmed: 26367797
Nat Genet. 2011 Oct 09;43(11):1066-73
pubmed: 21983784
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2
pubmed: 23535731
Nat Genet. 2018 Sep;50(9):1327-1334
pubmed: 30127527
Nat Genet. 2016 Apr;48(4):374-86
pubmed: 26928228
J Cell Biochem. 2013 Nov;114(11):2500-12
pubmed: 23749759
Nat Rev Mol Cell Biol. 2019 Apr;20(4):242-258
pubmed: 30610207
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Apr;1863(4):420-432
pubmed: 29414510
Am J Hum Genet. 2010 Oct 8;87(4):545-52
pubmed: 20887962
Int J Mol Sci. 2017 Jun 21;18(6):
pubmed: 28635626
Nature. 2001 May 31;411(6837):599-603
pubmed: 11385576
Front Genet. 2018 Nov 06;9:524
pubmed: 30459811
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10308-13
pubmed: 15210937
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nat Genet. 2010 Apr;42(4):348-54
pubmed: 20208533
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Int J Obes (Lond). 2018 Jun;42(5):1039-1050
pubmed: 29467502
PLoS Genet. 2017 Oct 30;13(10):e1007079
pubmed: 29084231
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Am J Hum Genet. 2018 May 3;102(5):717-730
pubmed: 29727686
J Biol Chem. 2003 Oct 10;278(41):40352-63
pubmed: 12878598
Endocrinology. 2015 Mar;156(3):934-46
pubmed: 25514086
Nat Genet. 2018 Jul;50(7):956-967
pubmed: 29955180
G3 (Bethesda). 2019 Aug 8;9(8):2521-2533
pubmed: 31186305
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Diabetes. 2008 Dec;57(12):3353-9
pubmed: 18776141
Hum Mol Genet. 2014 Feb 15;23(4):1108-19
pubmed: 24105470
Nat Commun. 2015 May 29;6:7211
pubmed: 26021296
J Lipid Res. 2017 Mar;58(3):481-493
pubmed: 28119442
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
Am J Hum Genet. 2015 Dec 3;97(6):801-15
pubmed: 26637976
Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901
pubmed: 27899670
Springerplus. 2012 Dec;1(1):66
pubmed: 23396303
Hum Mol Genet. 2011 Oct 15;20(20):4082-92
pubmed: 21798870
Nature. 2011 May 5;473(7345):43-9
pubmed: 21441907
Cell. 2018 Jan 25;172(3):393-407
pubmed: 29373828
Am J Hum Genet. 2019 Oct 3;105(4):773-787
pubmed: 31564431
Diabetes Care. 2013 Jan;36(1):166-75
pubmed: 23264288
Genet Epidemiol. 2012 Jul;36(5):451-62
pubmed: 22549815
PLoS One. 2011;6(10):e26792
pubmed: 22046359
Science. 2009 Apr 17;324(5925):387-9
pubmed: 19264985
Nat Genet. 2008 Feb;40(2):161-9
pubmed: 18193043